Wikipedia:Version 1.0 Editorial Team/Pharmacology articles by quality log

This is a log of operations by a bot. The contents of this page are unlikely to need human editing. In particular, links should not be disambiguated as this is a historical record.

May 25, 2024[edit]

Reassessed[edit]

Amrinone (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
BAY 73-6691 (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Carteolol (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Daprodustat (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Etrasimod (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Fezolinetant (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Nirogacestat (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Orteronel (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Perfluorohexyloctane (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Pirtobrutinib (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Repotrectinib (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Rezafungin (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Ritlecitinib (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Sotagliflozin (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Sparsentan (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Tiratricol (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Zilucoplan (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Β-Methylphenethylamine (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)

May 24, 2024[edit]

Reassessed[edit]

Y-27632 (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)

Removed[edit]

Draft:Mayur Shetty (talk) removed.

May 23, 2024[edit]

Reassessed[edit]

Pharmaceutical industry in China (talk) reassessed. Quality rating changed from Start-Class to B-Class. (rev · t) Importance rating changed from Mid-Class to High-Class. (rev · t)
Pharmaceutical industry in the United Kingdom (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t) Importance rating changed from Unknown-Class to High-Class. (rev · t)

Assessed[edit]

Depyrogenation (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)

May 22, 2024[edit]

Reassessed[edit]

Etodesnitazene (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Tomáš Cihlář (talk) reassessed. Quality rating changed from B-Class to C-Class. (rev · t)

Assessed[edit]

Dibucaine number (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)

May 21, 2024[edit]

Renamed[edit]

Caffeine/ergotamine renamed to Ergotamine/caffeine.
Draft:Justin English renamed to Justin English.

Reassessed[edit]

Axelopran (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Diosmectite (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Emopamil (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Empagliflozin/linagliptin/metformin (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Insulin glulisine (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Pegvaliase (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Urapidil (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)

Assessed[edit]

Creolin (talk) assessed. Quality assessed as C-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
Ergotamine/caffeine (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)

May 19, 2024[edit]

Renamed[edit]

Federal Food, Drug, and Cosmetic Act renamed to Federal Food, Drug, and Cosmetic Act of 1938.

Reassessed[edit]

Idarucizumab (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Oligodynamic effect (talk) reassessed. Quality rating changed from Unassessed-Class to Start-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)

Assessed[edit]

Federal Food, Drug, and Cosmetic Act of 1938 (talk) assessed. Quality assessed as C-Class. (rev · t) Importance assessed as Mid-Class. (rev · t)
Semapimod (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
Tarlatamab (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Mid-Class. (rev · t)
Category:Tobacco plantation owners (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)

Removed[edit]

Draft:Heman Bekele (talk) removed.